Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Nakasaki T et al. Effects of PAF on histamine H1 receptor mRNA expression in rat trigeminal ganglia. 1999 Prostaglandins Other Lipid Mediat. pmid:10482285
Kapui Z et al. Experimental studies on guanosine 3',5'-cyclic monophosphate levels and airway responsiveness of the novel phosphodiesterase type 5 inhibitor SR 265579 in guinea-pigs. 1999 Arzneimittelforschung pmid:10483515
Shah BH et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. 1999 Biochem. Pharmacol. pmid:10484074
Kültürsay N et al. Platelet-activating factor concentrations in healthy and septic neonates. 1999 Eur. J. Pediatr. pmid:10485307
Koyama N and Ogawa Y Elevated platelet activating factor in the tracheal aspirate at birth and signs of intra-uterine inflammation in infants with neonatal pulmonary emphysema. 1999 Eur. J. Pediatr. pmid:10486094
Piccolo MT et al. Chemotactic mediator requirements in lung injury following skin burns in rats. 1999 Exp. Mol. Pathol. pmid:10486240
Triggiani M et al. Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. 1999 Biochem. Pharmacol. pmid:10487538
Blackstone MO ICAM-1 in cerulein-induced pancreatitis. 1999 Gastroenterology pmid:10490367
Comellas A et al. Effect of platelet activating factor (PAF) on pulmonary circulation in isolated rabbit lung. 1999 J. Physiol. Biochem. pmid:10494654
GamaleÄ­ IA et al. [Post-receptor formation of active forms of oxygen in nonphagocytic cells]. 1999 Tsitologiia pmid:10496012
Dekkers PE et al. Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta in chimpanzees. 1999 Infect. Immun. pmid:10496934
Mitidieri F and de Meis L Ca(2+) release and heat production by the endoplasmic reticulum Ca(2+)-ATPase of blood platelets. Effect of the platelet activating factor. 1999 J. Biol. Chem. pmid:10497193
Marathe GK et al. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. 1999 J. Biol. Chem. pmid:10497200
Sakaguchi T et al. Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats. 1999 Hepatology pmid:10498648
Imrie CW and McKay CJ The scientific basis of medical therapy of acute pancreatitis. Could it work, and is there a role for lexipafant? 1999 Gastroenterol. Clin. North Am. pmid:10503138
Min JH et al. Membrane-bound plasma platelet activating factor acetylhydrolase acts on substrate in the aqueous phase. 1999 Biochemistry pmid:10504265
Tiemann U et al. Influence of inhibitors on increase in intracellular free calcium and proliferation induced by platelet-activating factor in bovine oviductal cells. 1999 J. Reprod. Fertil. pmid:10505057
Peplow PV Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10509861
Merendino N et al. Human intestinal epithelial cells express receptors for platelet-activating factor. 1999 Am. J. Physiol. pmid:10516147
Greenberg SG and Clark KE Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep. 1999 Am. J. Physiol. pmid:10516237
Bernatchez PN et al. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent. 1999 J. Biol. Chem. pmid:10521504
Sugiura T et al. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells. 1999 Biochim. Biophys. Acta pmid:10521703
Hocke M et al. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease. 1999 Jul-Aug Hepatogastroenterology pmid:10521992
Monteiro HS et al. Glomerular effects of cholera toxin in isolated perfused rat kidney: a potential role for platelet activating factor. 1999 Pharmacol. Toxicol. pmid:10522748
Prescott SM et al. Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury. 1999 J. Clin. Invest. pmid:10525039
Nagase T et al. Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. 1999 J. Clin. Invest. pmid:10525045
Wang X et al. Platelet-activating factor induced Ca(2+) signaling in human microglia. 1999 Brain Res. pmid:10526106
Kinlough-Rathbone RL et al. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. 1999 Thromb. Res. pmid:10527409
Sun Z et al. Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion. 1999 J. Surg. Res. pmid:10527709
Vergnolle N Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. 1999 J. Immunol. pmid:10528212
Stammberger U et al. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury. 1999 J. Heart Lung Transplant. pmid:10528748
Marr KA et al. Agonist-induced adherence of equine neutrophils to fibronectin- and serum-coated plastic is CD18 dependent. 1999 Vet. Immunol. Immunopathol. pmid:10532398
Serou MJ et al. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. 1999 J. Neurosci. Res. pmid:10533051
Mustafa SB et al. Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells. 1999 Hepatology pmid:10534342
Nicholson SC et al. Echocardiographic and survival studies in mice undergoing endotoxic shock: effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor. 1999 J. Surg. Res. pmid:10534424
McKenna CJ et al. Familial dilated cardiomyopathy. 1999 Circulation pmid:10534480
Tselepis AD et al. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy. 1999 Cardiovasc. Res. pmid:10536703
Ernest S and Bello-Reuss E Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. 1999 J. Am. Soc. Nephrol. pmid:10541289
Manya H et al. Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase. 1999 J. Biol. Chem. pmid:10542206
Koyama S et al. The potential of various lipopolysaccharides to release monocyte chemotactic activity from lung epithelial cells and fibroblasts. 1999 Eur. Respir. J. pmid:10543273
Echazarreta AL et al. Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma. 1999 Eur. Respir. J. pmid:10543284
Gómez FP et al. Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study. 1999 Eur. Respir. J. pmid:10543285
Uluoglu C and Timlioglu O Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF). 1999 Naunyn Schmiedebergs Arch. Pharmacol. pmid:10543435
Li S et al. Experimental therapy of a platelet-activating factor antagonist (ginkgolide B) on photochemically induced thrombotic cerebral ischaemia in tree shrews. 1999 Clin. Exp. Pharmacol. Physiol. pmid:10549411
Biancone L et al. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis. 1999 Am. J. Pathol. pmid:10550329
Wang MM et al. Stereoselective actions of hepoxilins A3 and B3 and their cyclopropane analogs (HxdeltaA3 and HxdeltaB3) on bradykinin and PAF-evoked potentiation of vascular leakage in rat skin. 1999 Gen. Pharmacol. pmid:10553878
Adunsky A et al. Infarct volume, neurological severity and PAF binding to platelets of patients with acute cerebral ischemic stroke. 1999 Neurol. Res. pmid:10555184
Falk S et al. Quinolines attenuate PAF-induced pulmonary pressor responses and edema formation. 1999 Am. J. Respir. Crit. Care Med. pmid:10556149
Lauener RW et al. A role for phosphatidylinositol 3-kinase in platelet aggregation in response to low, but not high, concentrations of PAF or thrombin. 1999 Biochim. Biophys. Acta pmid:10559473
Fuentes E et al. Lysophospholipids trigger calcium signals but not DNA synthesis in cortical astrocytes. 1999 Glia pmid:10559786